Imprimis Pharmaceuticals Inc. plans to raise $9.8 million in a private placement of units.
The company will issue 5.1 million units at $1.915 apiece with each unit comprising 1 stock and a warrant to purchase another Imprimis share for $1.79 apiece within three years from issue.
The warrants are nonexercisable within the first six months of issue.
Funds raised will help Imprimis advance its eye business. The offering is expected to close Dec. 23 with National Securities Corp. acting as exclusive placement agent.